Revoi.in

Business

Torrent Pharma to acquire controlling stake in J. B. Chemicals & Pharmaceuticals from KKR

June 29, 2025 revoi editor

Mumbai, 29th Jun 2025: Torrent Pharmaceuticals Limited (“Torrent”) and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals (“JB Pharma”) from KKR at an Equity Valuation of INR 25,689 crores (on fully diluted basis), followed by a merger of the two […]

Business

Torrent Pharma : Aman Mehta appointed as Managing Director

May 20, 2025 revoi editor

Torrent Pharma said, Aman Mehta, currently Whole-time Director, Torrent Pharmaceuticals Limited, holds a degree in Economics from Boston University and an MBA from Columbia University, New York. During his journey with the Group, he has held leadership roles across both Power and Pharma verticals. In his role as Executive Director at Pharma, he was primarily […]

Business

Torrent Pharma announces Q2 FY25 results

October 25, 2024 revoi editor

Torrent Pharma announces Q2 FY25 results. Revenue at Rs. 2,889 crores grew by 9%, Gross Margin: 76.5%, Op. EBITDA margin at 32.5%. Op. EBITDA at Rs.939 crores, up by 14%. Net Profit after tax at Rs. 453 crores, up by 17%, Insulin revenues were impacted this quarter due to scheduled shutdown taken in the month […]

Business

Torrent Pharma announces Q1 FY25 results

July 23, 2024 Vinayak Barot

Revenue & profitability: Revenue at Rs. 2,859 crores grew by 10% Gross Margin: 75.7%, Op. EBITDA margin at 31.6%, Growth: 14% Net Profit after tax at Rs. 457 crores, up by 21% Other expenses include one-off expenses of Rs. 20 crores (in international business) Adjusted for such one-off expenses, the underlying Op. EBITDA is Rs. […]

Business

Torrent Pharma Q4 Results, Net profit jumps 57%

May 24, 2024 Vinayak Barot

Drug firm Torrent Pharmaceuticals Ltd on Friday (May 24) reported a 56.5% year-on-year (YoY) jump in net profit at ₹449 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, Torrent Pharmaceuticals posted a net profit of ₹287 crore, the company said in a regulatory filing. The company’s revenue from operations […]

Business

Torrent Pharma announces Q2 FY24 results, Branded markets continue to deliver strong growth

October 23, 2023 Vinayak Barot

Ahmedabad, October 23, 2023: India: India revenue at Rs 1,444 crores grew by 18% As per AIOCD secondary market data, IPM growth for the quarter was 4%. ∙ Market outperformance was led by continued double digit growth in chronic therapies, revival in gastro demand, traction in consumer division, and new launches. ∙ Curatio portfolio grew […]

Business

Torrent Pharma announces Q1 FY24 results, Revenue at Rs. 2,591 crores up by 10%

August 9, 2023 Vinayak Barot

Revenue & profitability: Revenue at Rs. 2,591 crores up by 10%. Gross margin: 74.9%; Op. EBITDA: 30.5% Op. EBITDA at Rs. 791 crores up by 11%. Adjusted for one off income in both periods, it is up by 16%. Profit after tax at Rs. 378 crores Performance summary: Results Q1 FY24 Q1 FY23 YoY% Rs […]

Business

Torrent Pharma announces Q1 FY24 results

August 7, 2023 Vinayak Barot

Revenue & profitability: ∙ Revenue at Rs. 2,591 crores up by 10%. ∙ Gross margin: 74.9%; Op. EBITDA: 30.5% ∙ Op. EBITDA at Rs. 791 crores up by 11%. Adjusted for one off income in both periods, it is up by 16%. ∙ Profit after tax at Rs. 378 crores Performance summary: Results Q1 FY24 […]